Effects of IFN-β, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls

Journal of Neuroimmunology

Volumn 177, Issue 1-2, 2006, Pages 189-200

  Vanderlocht, Joris ^a   Hendriks, Jerome J A ^a   Venken, Koen ^a   Stinissen, Piet ^a   Hellings, Niels ^a  

^a HASSELT UNIVERSITY   (Belgium)

Author keywords

Immunotherapy; Leukemia inhibitory factor; Multiple sclerosis; Neuroprotection

Indexed keywords

BETA INTERFERON; CYTOKINE; LEPTIN; LEUKEMIA INHIBITORY FACTOR; SIMVASTATIN;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; MALE; MONOCYTE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 33746299181     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.04.012     Document Type: Article

References (60)

1. Azari M.F., Galle A., Lopes E.C., Kurek J., and Cheema S.S. Leukemia inhibitory factor by systemic administration rescues spinal motor neurons in the SOD1 G93A murine model of familial amyotrophic lateral sclerosis. Brain Res. 922 (2001) 144-147
2. Barouch R., and Schwartz M. Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity. FASEB J. 16 (2002) 1304-1306
3. Barres B.A., Schmid R., Sendnter M., and Raff M.C. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118 (1993) 283-295
4. Barth H., Klein K., Bortlein A., Guseo A., Berg P.A., Wietholter H., and Klein R. Analysis of immunoregulatory T-helper cell subsets in patients with multiple sclerosis: relapsing-progressive course correlates with enhanced T H1, relapsing-remitting course with enhanced T H0 reactivity. J. Neuroimmunol. 133 (2002) 175-183
5. Ben Nun A., Wekerle H., and Cohen I.R. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11 (1981) 195-199
6. Blesch A., Uy H.S., Grill R.J., Cheng J.G., Patterson P.H., and Tuszynski M.H. Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury. J. Neurosci. 19 (1999) 3556-3566
7. Butzkueven H., Zhang J.G., Soilu-Hanninen M., Hochrein H., Chionh F., Shipham K.A., Emery B., Turnley A.M., Petratos S., Ernst M., Bartlett P.F., and Kilpatrick T.J. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat. Med. 8 (2002) 613-619
8. Byskosh P.V., and Reder A.T. Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis. Mult. Scler. 1 (1996) 262-269
9. Chiang J., Gloff C.A., Yoshizawa C.N., and Williams G.J. Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin. Pharm. Res. 10 (1993) 567-572
10. Dandekar A.A., Wu G.F., Pewe L., and Perlman S. Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus. J. Virol. 75 (2001) 6115-6120
11. D'Souza S.D., Alinauskas K.A., and Antel J.P. Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J. Neurosci. Res. 43 (1996) 289-298
12. Frenkel D., Huang Z., Maron R., Koldzic D.N., Moskowitz M.A., and Weiner H.L. Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J. Neurol. Sci. 233 (2005) 125-132
13. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
14. Giuliani F., Goodyer C.G., Antel J.P., and Yong V.W. Vulnerability of human neurons to T cell-mediated cytotoxicity. J. Immunol. 171 (2003) 368-379
15. Gonzalez R.R., Rueda B.R., Ramos M.P., Littell R.D., Glasser S., and Leavis P.C. Leptin-induced increase in leukemia inhibitory factor and its receptor by human endometrium is partially mediated by interleukin 1 receptor signaling. Endocrinology 145 (2004) 3850-3857
16. Hammarberg H., Lidman O., Lundberg C., Eltayeb S.Y., Gielen A.W., Muhallab S., Svenningsson A., Linda H., Der Meide P.H., Cullheim S., Olsson T., and Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 20 (2000) 5283-5291
17. Hermans G., Stinissen P., Hauben L., Berg-Loonen E., Raus J., and Zhang J. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals. Ann. Neurol. 42 (1997) 18-27
18. Hughes R.A., Sendtner M., and Thoenen H. Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J. Neurosci. Res. 36 (1993) 663-671
19. Kerr B.J., and Patterson P.H. Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury. Glia 51 (2005) 73-79
20. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., and Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J. Exp. Med. 189 (1999) 865-870
21. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E.F., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., and Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J. Exp. Med. 189 (1999) 865-870
22. Khan O.A., Xia Q., Bever Jr. C.T., Johnson K.P., Panitch H.S., and Dhib-Jalbut S.S. Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration. Neurology 46 (1996) 1639-1643
23. Kieseier B.C., Archelos J.J., and Hartung H.P. Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases. Arch. Neurol. 61 (2004) 929-932
24. Lecoeur H., de Oliveira-Pinto L.M., and Gougeon M.L. Multiparametric flow cytometric analysis of biochemical and functional events associated with apoptosis and oncosis using the 7-aminoactinomycin D assay. J. Immunol. Methods 265 1-2 (2002) 81-96
25. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., and Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8 (2002) 500-508
26. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., and Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8 (2002) 500-508
27. Loffreda S., Yang S.Q., Lin H.Z., Karp C.L., Brengman M.L., Wang D.J., Klein A.S., Bulkley G.B., Bao C., Noble P.W., Lane M.D., and Diehl A.M. Leptin regulates proinflammatory immune responses. FASEB J. 12 (1998) 57-65
28. Lord G.M., Matarese G., Howard J.K., Baker R.J., Bloom S.R., and Lechler R.I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394 (1998) 897-901
29. Martinou J.C., Martinou I., and Kato A.C. Cholinergic differentiation factor (Cdf/Lif) promotes survival of isolated rat embryonic motoneurons in vitro. Neuron 8 (1992) 737-744
30. Matarese G., Di Giacomo A., Sanna V., Lord G.M., Howard J.K., Di Tuoro A., Bloom S.R., Lechler R.I., Zappacosta S., and Fontana S. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J. Immunol. 166 (2001) 5909-5916
31. Matarese G., Sanna V., Di Giacomo A., Lord G.M., Howard J.K., Bloom S.R., Lechler R.I., Fontana S., and Zappacosta S. Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur. J. Immunol. 31 (2001) 1324-1332
32. Mayer M., Bhakoo K., and Noble M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120 (1994) 143-153
33. Mazurek N., Weskamp G., Erne P., and Otten U. Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels. FEBS Lett. 198 (1986) 315-320
34. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Yauch R.L., Neville K.L., Katz-Levy Y., Carrizosa A., and Kim B.S. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3 (1997) 1133-1136
35. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., and Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5 (1999) 49-55
36. Moalem G., Gdalyahu A., Shani Y., Otten U., Lazarovici P., Cohen I.R., and Schwartz M. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J. Autoimmun. 15 (2000) 331-345
37. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 1-2 (1983) 55-63
38. Neuhaus O., Strasser-Fuchs S., Fazekas F., Kieseier B.C., Niederwieser G., Hartung H.P., and Archelos J.J. Statins as immunomodulators: comparison with interferon-beta 1b in MS. Neurology 59 (2002) 990-997
39. Neuhaus O., Stuve O., Archelos J.J., and Hartung H.P. Putative mechanisms of action of statins in multiple sclerosis-comparison to interferon-beta and glatiramer acetate. J. Neurol. Sci. 233 (2005) 173-177
40. Novikov L., Novikova L., and Kellerth J.O. Brain-derived neurotrophic factor promotes survival and blocks nitric oxide synthase expression in adult rat spinal motoneurons after ventral root avulsion. Neurosci. Lett. 200 (1995) 45-48
41. Olsson T., Diener P., Ljungdahl A., Hojeberg B., van der Meide P.H., and Kristensson K. Facial nerve transection causes expansion of myelin autoreactive T cells in regional lymph nodes and T cell homing to the facial nucleus. Autoimmunity 13 (1992) 117-126
42. Otten U., Ehrhard P., and Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 10059-10063
43. Pan W., Kastin A.J., and Brennan J.M. Saturable entry of leukemia inhibitory factor from blood to the central nervous system. J. Neuroimmunol. 106 (2000) 172-180
44. Pettinelli C.B., and McFarlin D.E. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+2-T lymphocytes. J. Immunol. 127 (1981) 1420-1423
45. Piccinni M.P., Beloni L., Livi C., Maggi E., Scarselli G., and Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat. Med. 4 (1998) 1020-1024
46. Pouly S., and Antel J.P. Multiple sclerosis and central nervous system demyelination. J. Autoimmun. 13 (1999) 297-306
47. Pouly S., Antel J.P., Ladiwala U., Nalbantoglu J., and Becher B. Mechanisms of tissue injury in multiple sclerosis: opportunities for neuroprotective therapy. J. Neural (2000) 193-203
48. Sagot Y., Vejsada R., and Kato A.C. Clinical and molecular aspects of motoneurone diseases: animal models, neurotrophic factors and Bcl-2 oncoprotein. Trends Pharmacol. Sci. 18 (1997) 330-337
49. Schwartz M., and Kipnis J. Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift. Neuroscientist 8 (2002) 405-413
50. Semkova I., and Krieglstein J. Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors. Brain Res. Brain Res. Rev. 30 (1999) 176-188
51. Sorensen T.L., and Sellebjerg F. Distinct chemokine receptor and cytokine expression profile in secondary progressive MS. Neurology 57 (2001) 1371-1376
52. Steinman L., and Zamvil S. Transcriptional analysis of targets in multiple sclerosis. Nat. Rev. Immunol. 3 (2003) 483-492
53. Sugiura S., Lahav R., Han J., Kou S.Y., Banner L.R., de Pablo F., and Patterson P.H. Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. Eur. J. Neurosci. 12 (2000) 457-466
54. Thorpe L.W., and Perez-Polo J.R. The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes. J. Neurosci. Res. 18 (1987) 134-139
55. Vanderlocht J., Hellings N., Vandenabeele F., Hendriks J., Moreels M., Buntinx M., Hoekstra D., Antel J., and Stinissen P. Leukemia inhibitory factor (LIF) is produced by myelin reactive T cells from multiple sclerosis patients and protects against TNF-alpha induced oligodendrocyte apoptosis. J. Neurosci. Res. 83 5 (2006) 736-774
56. Vanderlocht J., Burzykowski T., Somers V., Stinissen P., and Hellings N. No association of leukemia inhibitory factor (LIF) DNA polymorphisms with multiple sclerosis. J. Neuroimmunol. 171 1-2 (2006) 189-192
57. Vargas-Leal V., Bruno R., Derfuss T., Krumbholz M., Hohlfeld R., and Meinl E. Expression and function of glial cell line-derived neurotrophic factor family ligands and their receptors on human immune cells. J. Immunol. 175 (2005) 2301-2308
58. Wang W.Z., Olsson T., Kostulas V., Hojeberg B., Ekre H.P., and Link H. Myelin antigen reactive T cells in cerebrovascular diseases. Clin. Exp. Immunol. 88 (1992) 157-162
59. Yoles E., Hauben E., Palgi O., Agranov E., Gothilf A., Cohen A., Kuchroo V., Cohen I.R., Weiner H., and Schwartz M. Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci. 21 (2001) 3740-3748
60. Youssef S., Stuve O., Patarroyo J.C., Ruiz P.J., Radosevich J.L., Hur E.M., Bravo M., Mitchell D.J., Sobel R.A., Steinman L., and Zamvil S.S. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420 (2002) 78-84